Dr. Edward Licitra of RCCA’s Central Jersey Division recently participated in The American Journal of Managed Care® (AJMC®) latest virtual peer-to-peer panel discussion titled, “Implications of Expanding Use of CAR T-Cell Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)”.
Dr. Licitra was joined by a panel of experts who discussed the clinical impact of the use of CAR T-cell therapy in relapsed/refractory non-Hodgkin’s lymphoma and important considerations and implications for expanding use of CAR T into the community practice setting
Click here to view the video discussion series
